AI Verdict
NHC has stronger fundamentals based on our AI analysis.
NHC vs NGNE Fundamental Comparison
| Metric | NHC | NGNE |
|---|---|---|
| Revenue | $1.5B | $0.0 |
| Net Income | $120.0M | $-90.4M |
| Net Margin | 7.9% | N/A |
| ROE | 11.2% | -34.1% |
| ROA | 7.9% | -31.3% |
| Current Ratio | 1.82x | 16.56x |
| Debt/Equity | 0.04x | 0.00x |
| EPS | $7.67 | $-4.24 |
Green = Better metric | Red = Weaker metric
You Might Also Compare
NHC vs NGNE: Frequently Asked Questions
Is NHC or NGNE a better buy in 2026?
Based on dual AI fundamental analysis (Claude and ChatGPT), NHC has stronger fundamentals. NHC is rated BUY (72% confidence) while NGNE is rated SELL (85% confidence). This is not investment advice.
How does NHC compare to NGNE fundamentally?
NATIONAL HEALTHCARE CORP has ROE of 11.2% vs Neurogene Inc.'s -34.1%. Net margins are 7.9% vs N/A respectively.
Which stock pays higher dividends, NHC or NGNE?
NHC has a dividend yield of N/A or no dividend while NGNE has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.
Should I invest in NHC or NGNE for long term?
For long-term investing, consider that NHC has BUY rating with 72% confidence, while NGNE has SELL rating with 85% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.
What do the AI models say about NHC vs NGNE?
Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For NHC vs NGNE, the AI consensus favors NHC based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.